• Join Our Team
Curant Health
  • Home
  • About
  • For Patients
  • Providers
  • Health Plans
  • Pharma
  • Employers
  • Contact Us
Select Page

How to smooth the patient access path to life-altering therapies

by Administrator | Oct 16, 2015 | blog

The newly approved PCSK9 inhibitors are a major advance in cholesterol-lowering drug therapy.  Gregory Curfman, MD and Editor in Chief of Harvard Health Publications, has said that this advanced therapy may just rewrite the script for treating patients with chronic...

Recent Posts

  • Curant Health Appoints U.S Market Leadership for Employer and Health Plan Markets
  • Curant Health Honored With Inc. Best In Business Award In Health Services Category
  • Curant Health and Humana Launch Pilot Program to Address Medication Adherence and Enhance Patient Care for Members with Complex Health Needs
  • Benchworks Partners With Curant Health to Provide Outcomes-based Consulting
  • Validation Institute Certifies Curant Health’s Total Cost of Care Reduction for Chronically-Ill Patients

Recent Comments

    • Terms & Conditions
    • Web Policies
    • Privacy Practices
    • Careers
    ×

    ×

    Get in Touch

    Contact Info

    (404) 217-4896

    CurantMeansCare@curanthealth.com